- Home
- OUST vs CLDX Comparison
OUST vs CLDX Comparison
Compare OUST & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUST | CLDX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 320 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | OUST | CLDX |
|---|---|---|
| Price | $38.39 | $29.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $39.25 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 5.4M | 692.1K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $33.20 | $111.39 |
| Revenue Next Year | $37.27 | $235.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $16.40 | $19.52 |
| 52 Week High | $49.39 | $35.83 |
Technical Indicators
Market Signals| Indicator | OUST | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 41.74 |
| Support Level | $26.62 | $28.55 |
| Resistance Level | $39.17 | $30.90 |
| Average True Range (ATR) | 5.00 | 1.06 |
| MACD | -0.77 | -0.13 |
| Stochastic Oscillator | 42.80 | 25.80 |
Price Performance
Historical ComparisonAbout OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.